Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
PaperCitations, authors & open-access status
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 159 citations, 2022 year and hybrid oa status.
159
Citations
2022
Year
hybrid
OA Status